AnalystsAndreas ArgyridesAndreas Argyrides's Stock Forecasts
AnalystsAndreas Argyrides
Sectors:
Analyst Ranking
Top 12%
#521 out of 4587 analysts
Average Return
+13.14%
Win Rate
50%36 out of 72
Risk vs Reward
Poor
Good
Andreas Argyrides's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aquestive Therapeutics IncAQST | +502.47% | $0.81 | $4.88 | 2023-03-08 - 2024-03-08 | Buy |
Moonlake ImmunotherapeuticsMLTX | +146.45% | $21.25 | $52.37 | 2023-03-21 - 2024-03-21 | Buy |
Ars Pharmaceuticals IncSPRY | +146.05% | $3.67 | $9.03 | 2023-09-20 - 2024-05-17 | Buy |
Albireo Pharma IncALBO | +142.53% | $18.08 | $43.85 | 2022-08-15 - 2023-01-09 | Buy |
Ars Pharmaceuticals IncSPRY | +125.75% | $4.00 | $9.03 | 2023-11-12 - 2024-05-17 | Buy |
Andreas Argyrides Analyst Color
Get additional color on Andreas Argyrides's coverage of popular stocks
Andreas Argyrides's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | 13 | Buy | $92.00 | +131.45% | Reiterates | 2 months ago |
Ars Pharmaceuticals IncSPRY | 9 | Buy | $19.00 | +110.41% | Reiterates | 2 months ago |
Aquestive Therapeutics IncAQST | 4 | Buy | $9.00 | +189.39% | Maintains | 2 months ago |
Gossamer Bio IncGOSS | 7 | Buy | $6.00 | +764.55% | Reiterates | 2 months ago |
Oculis Holding AgOCS | 3 | Buy | $29.00 | +142.17% | Reiterates | 2 months ago |
Regenxbio IncRGNX | 4 | Hold | $21.00 | +31.33% | Reiterates | 3 months ago |
Sarepta Therapeutics IncSRPT | 4 | Buy | $224.00 | +70.50% | Reiterates | 3 months ago |
Pacira Biosciences IncPCRX | 2 | Buy | $57.00 | +84.94% | Reiterates | 3 months ago |
Ascendis Pharma AASND | 8 | Buy | $225.00 | +85.77% | Maintains | 3 months ago |
Rani Therapeutics Holdings IncRANI | 3 | Buy | $8.00 | +53.26% | Reiterates | 3 months ago |
Liquidia CorpLQDA | 5 | Sell | $3.00 | -76.40% | Reiterates | 5 months ago |
Keros Therapeutics IncKROS | 4 | Buy | $86.00 | +64.50% | Reiterates | 6 months ago |
Immunic IncIMUX | 3 | Buy | $7.00 | +462.25% | Maintains | 7 months ago |
Mannkind CorpMNKD | 1 | Buy | $10.00 | +117.86% | Initiates Coverage On | 7 months ago |
Sangamo Therapeutics IncSGMO | 3 | Buy | $10.00 | +1,438.46% | Maintains | 9 months ago |
Biomarin Pharmaceutical IncBMRN | 6 | Hold | $70.00 | -9.75% | Maintains | 10 months ago |
Unity Biotechnology IncUBX | 4 | Hold | $2.00 | +35.14% | Downgrades | a year ago |
Albireo Pharma IncALBO | 2 | Hold | $42.00 | N/A | Downgrades | a year ago |
Global Blood Therapeutics IncGBT | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.